| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.97M | 30.46M | 26.77M | 25.46M | 22.92M | 20.39M |
| Gross Profit | 29.91M | 25.49M | 21.20M | 20.78M | 18.52M | 16.67M |
| EBITDA | 1.23M | 2.77M | 2.27M | 867.00K | -1.54M | -655.00K |
| Net Income | -203.00K | 1.10M | 845.00K | -497.00K | -2.73M | 8.99M |
Balance Sheet | ||||||
| Total Assets | 44.84M | 33.02M | 30.04M | 28.28M | 24.00M | 29.43M |
| Cash, Cash Equivalents and Short-Term Investments | 13.27M | 20.59M | 17.61M | 15.38M | 13.75M | 16.62M |
| Total Debt | 1.48M | 212.00K | 308.00K | 464.00K | 640.00K | 817.00K |
| Total Liabilities | 35.70M | 23.15M | 21.23M | 20.42M | 15.48M | 18.92M |
| Stockholders Equity | 9.14M | 9.88M | 8.80M | 7.87M | 8.52M | 10.51M |
Cash Flow | ||||||
| Free Cash Flow | 7.03M | 3.39M | 2.31M | 2.07M | -2.72M | 4.11M |
| Operating Cash Flow | 7.13M | 4.53M | 3.85M | 3.05M | -2.26M | 4.21M |
| Investing Cash Flow | 25.50K | 5.11M | -4.58M | -932.00K | -457.00K | 14.56M |
| Financing Cash Flow | -233.50K | -116.00K | -169.00K | -173.00K | -198.00K | -5.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £434.69M | 11.06 | 58.56% | 3.58% | 18.44% | 33.73% | |
68 Neutral | £120.39M | -33.80 | -0.19% | ― | 31.86% | -115.22% | |
68 Neutral | £163.66M | 37.63 | 5.22% | 0.80% | 22.80% | -32.13% | |
65 Neutral | £321.01M | 52.26 | 7.57% | 1.04% | 10.93% | 12.30% | |
65 Neutral | £836.72M | 13.89 | 25.32% | 2.85% | 2.15% | -39.26% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £19.44M | -1.93 | -29.25% | ― | 10.00% | 34.02% |